Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

NCT06447376

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06544785

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: H. General Univ. de Alicante Alicante, Spain

H. Clínic de Barcelona Barcelona, Spain

H. Vall d' Hebron Barcelona, Spain

Hospital del Mar Barcelona, Spain

View all 19 locations

View Trial Details

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974

Conditions: Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

NCT04573140

Conditions: Adult Glioblastoma, Astrocytoma, Brain Diseases, +25 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

UF Health Gainesville, Florida, United States

View Trial Details

Recruiting

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

NCT04068597

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +27 more
Locations: Emory Winship Cancer Institute Atlanta, Georgia, United States

Community Health Network Indianapolis, Indiana, United States

The Center for Cancer and Blood Disorders (CCBD) Bethesda, Maryland, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

View all 39 locations

View Trial Details

Recruiting

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

NCT07468136

Conditions: Anaplastic Oligodendroglioma, Astrocytoma, Astrocytoma, IDH-Mutant, Grade 3, +22 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT03516617

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

TSC Biosample Repository and Natural History Database

NCT05676099

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: University of Alabama Birmingham Birmingham, Alabama, United States

Loma Linda University Children's Hospital Loma Linda, California, United States

University of California Los Angeles Los Angeles, California, United States

Jack & Julia Center for TSC, Oakland Children's Hospital and Research Center Oakland, California, United States

View all 26 locations

View Trial Details

Recruiting

Study of the Disease Process of Lymphangioleiomyomatosis

NCT00001465

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +28 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

NCT03829540

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

Riley Hospital for Children Indianapolis, Indiana, United States

Albert Einstein Health Network New York, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions